Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mozobil and WBRT in newly diagnosed glioblastoma
NCT03746080Phase 2Completed
- Sponsor
- Lawrence D Recht
- Start
- Dec 2018
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in glioblastoma (GBM), sponsored by Lawrence D Recht. Started Dec 2018; status: completed.
02
Drugs
plerixafor
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT03746080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03746080.